| Literature DB >> 34136212 |
Obada Hasan1, Shah Fahad2, Mohammad Mustafa3, Pervaiz Hashmi4, Shahryar Noordin4.
Abstract
BACKGROUND: Routine preoperative tests in healthy patients not only cause extra anxiety, but may delay treatment without influencing surgical plan. This has worse impact in resource-constrained settings where fee for service rather than health insurance is the usual norm. Investigators aim to determine if "routine" pre-operative tests are justified in healthy orthopedic patients.Entities:
Keywords: Orthopedic patient; Preoperative evaluation; Resource-constrained setting
Year: 2021 PMID: 34136212 PMCID: PMC8181773 DOI: 10.1016/j.amsu.2021.102439
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Flow chart.
Demographic and clinical characteristics of cases and controls.
| Variables | Cases n = 71 | Controls n = 599 | P value | Variables | Cases n = 71 | Controls n = 599 | P value (0.05) |
|---|---|---|---|---|---|---|---|
| 6 | 5.5 | 0.14 | |||||
| 0.43 | |||||||
| 0–14 years | 1 (1%) | 101 (17%) | Compliance | 13 (18%) | 134 (22%) | ||
| 15–65 years | 44 (62%) | 386 (64%) | Non compliance | 58 (82%) | 465 (78%) | ||
| 65+ years | 26 (37%) | 112 (19%) | 0.13 | ||||
| 0.17 | |||||||
| Male | 44 (62%) | 320 (53%) | Compliance | 19 (27%) | 215 (36%) | ||
| Female | 27 (38%) | 279 (47%) | Non compliance | 52 (73%) | 384 (64%) | ||
| Arthroplasty | 6 (8%) | 178 (30%) | Intermediate | 45 (37%) | 273 (46%) | ||
| Trauma | 46 (65%) | 297 (50%) | Major | 26 (63%) | 325 (54%) | ||
| Oncology | 12 (17%) | 69 (11%) | 0.15 | ||||
| Sports | 7 (10%) | 55 (9%) | ASA-1 | 12 (17%) | 148 (25%) | ||
| ASA-2 | 59 (83%) | 451 (75%) | |||||
Proportions in the two groups are compared using Chi-square test and Wald χ2 test from simple logistic regression model, while median ± IQR for the skewed data (LOS) and their p value by Mann Whitney U test. P value of ≤0.05 is significant.
Unconditional logistic regression analysis at the Univariate level for the factors associated with change in surgical plan after admission reporting crude odds ratio OR and 95% confidence interval C.I..
| Variables | Cases n = 71 | Controls n = 599 | OR (C.I) | |
|---|---|---|---|---|
| 49.92 | 41.14 | 1.02 (1.01–1.03) | ||
| 5.96 | 5.46 | 1.04 (0.97–1.11) | 0.26 | |
| Male (Ref.) | 44 (62%) | 320 (53%) | 1 | |
| Female | 27 (38%) | 279 (47%) | 0.70 (0.42–1.17) | |
| Arthroplasty (Ref.) | 6 (8%) | 178 (30%) | 1 | |
| Trauma | 46 (65%) | 297 (50%) | 4.59 (1.92–10.98) | |
| Oncology | 12 (17%) | 69 (11%) | 5.15 (1.86–14.29) | |
| Sports | 7 (10%) | 55 (9%) | 3.78 (1.22–11.71) | |
| ASA-1(Ref.) | 12 (17%) | 148 (25%) | 1 | |
| ASA-2 | 59 (83%) | 451 (75%) | 1.61 (0.84–3.08) | |
| Normal ( | 36 (51%) | 376 (63%) | 1 | |
| Abnormal | 35 (49%) | 221 (37%) | 1.65 (1.01–2.71) | |
| Not Advised | 55 (77%) | 465 (78%) | 1 | |
| Normal | 3 (4%) | 56 (9%) | 0.45 (0.13–1.50) | |
| Abnormal | 13 (18%) | 78 (13%) | 1.41 (0.74–2.70) | |
Hb level test was advised to all patients.
Final model after multivariable analysis for factors associated with change in surgical plan.
| Variables | aOR (C.I) | |
|---|---|---|
| 0.28 | ||
| Normal (Ref.) | 1 | |
| Abnormal | 1.30 (0.79–2.30) | |
| 1.07 (0.83–1.39) | 0.59 | |
| 1.10 (0.89–1.35) | 0.37 | |
| 1.01 (0.84–1.22) | 0.90 | |
| 0.78 | ||
| Not advices (Ref.) | 1 | |
| Normal | 0.84 (0.24–2.95) | |
| Abnormal | 1.80 (0.87–3.74) | |
| 1.03 (1.01–1.04) | ||
| Arthroplasty (Ref.) | 1 | |
| Trauma | 7.44 (2.89–19.15) | |
| Oncology | 9.76 (3.26–29.20) | |
| Sports | 6.40 (1.98–20.75) | |
| Male (Ref.) | 1 | |
| Female | 0.55 (0.30–1.00) |
aOR: Adjusted Odds Ratio. C.I.: 95% Confidence Interval. P value of ≤0.05 is significant.
* Variables after principal component analysis; Acute Inflammatory Markers (WBC & Platelets), Coagulation profile (PT, APTT, INR) and UCE (Urea, Creatinine, serum Electrolytes = Sodium, Potassium, Chloride and Bicarbonate).
Conditional logistic regression was used at univariate and multivariable levels after matching the cases and controls on age, gender and procedure.
| Primary exposure | MOR (C.I) Cases = 66 Controls = 171 | MaOR (C.I.) Cases = 66 Controls = 171 | ||
|---|---|---|---|---|
| 0.06 | 0.08 | |||
| Normal (Ref.) | 1 | 1 | ||
| Abnormal | 1.85 (0.98–3.49) | 1.78 (0.93–3.43) | ||
| 1.21 (0.89–1.64) | 0.22 | 1.18 (0.86–1.60) | 0.31 | |
| 1.07 (0.85–1.36) | 0.55 | 1.10 (0.85–1.43) | 0.48 | |
| 0.95 (0.78–1.15) | 0.60 | 0.89 (0.71–1.12) | 0.32 | |
| 0.08 | 0.44 | |||
| Not advices (Ref.) | 1 | 1 | ||
| Normal | 0.47 (0.13–1.76) | 0.60 (0.16–2.24) | ||
| Abnormal | 2.28 (0.89–5.90) | 2.23 (0.85–5.84) |
MOR: crude Matched Odds Ratio. MaOR: Matched Adjusted Odds Ratio in multivariable model. C.I.: 95% Confidence Interval. P value of ≤0.05 is significant for the primary exposure.
| ASA 1 | ASA2 | |
|---|---|---|
| Full blood count | Not routinely | Not routinely |
| Haemostasis | Not routinely | Not routinely |
| Kidney Function | Not routinely | Consider in people at risk of AKI |
| ECG | Not routinely | Consider for people with cardiovascular, renal or diabetes comorbidities |
| ASA 1 | ASA2 | |
|---|---|---|
| Full blood count | Yes | Yes |
| Haemostasis | Not routinely | Not routinely |
| Kidney Function | Consider in people at risk of AKI | Yes |
| ECG | Consider for people aged over 65 if no ECG results available from past 12 months | Yes |